About the beginning of testing Areplivir in clinics – in the report of «Russia» TV channel: opinions of patients, doctors and scientists
Promomed 22 June 2020
Clinical trials of Areplivir developed at Biokhimik have begun in Mordovia.
It is assumed that it will become the main drug in the fight against the new coronavirus infection. The active substance efficacy is being studied simultaneously in 29 more countries. The reporters of «Vesti» TV program («Russia 1» channel) managed to get into the red zone of a covid hospital and listen to the opinions of patients, doctors and scientists about the «drug of hope».
It is assumed that it will become the main drug in the fight against the new coronavirus infection. The active substance efficacy is being studied simultaneously in 29 more countries. The reporters of «Vesti» TV program («Russia 1» channel) managed to get into the red zone of a covid hospital and listen to the opinions of patients, doctors and scientists about the «drug of hope».
